Vivoryon Therapeutics N.V.

VVY.AS · AMS
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-€5-€7-€14-€18
Dep. & Amort.€0€0€0€0
Deferred Tax€0€0€0€0
Stock-Based Comp.€1€0€1€2
Change in WC€0€0€0€12
Other Non-Cash€0€1-€1€3
Operating Cash Flow-€4-€6-€13-€1
Investing Activities
PP&E Inv.-€0-€0€0-€1
Net Acquisitions€0€0€0€0
Inv. Purchases€0€0€0-€19
Inv. Sales/Matur.€0€0€10€9
Other Inv. Act.€0€0€0€0
Investing Cash Flow-€0-€0€10-€11
Financing Activities
Debt Repay.-€0€0-€0€0
Stock Issued€0€0€0€3
Stock Repurch.€0€0€0€0
Dividends Paid€0€0€0€0
Other Fin. Act.€0-€0€0-€2
Financing Cash Flow-€0-€0-€0€1
Forex Effect€0-€0€0-€0
Net Chg. in Cash-€5-€6-€3-€11
Supplemental Information
Beg. Cash€9€15€19€30
End Cash€5€9€15€19
Free Cash Flow-€5-€6-€13-€1